Tech Company Financing Transactions
InterVene Funding Round
3x5 Special Opportunity Partners, Boston Scientific Corporation and Correlation Ventures joined a $15 million Series B funding round for InterVene. The round was announced on 6/27/2019.
Transaction Overview
Company Name
Announced On
6/27/2019
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
The funds will be utilized to expand our clinical research program abroad, and to initiate trials in the U.S. via an Investigational Device Exemption study.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
415 Grand Ave. 302
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
InterVene is an up and coming medical device start-up company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fletcher Wilson
Chief Operating Officer
Jeffrey Elkins
VP - R & D
Michi Garrison
VP - Regulatory Affairs
Tracy Roberts
Browse more venture capital transactions:
Prev: 6/27/2019: Cameo venture capital transaction
Next: 6/27/2019: Carbon venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs